Poland· PL-100457685
Voxzogo
A vosoritide product containing vosoritidum, registered in Poland by BioMarin International Ltd.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Vosoritide is registered in 10 of 19 countries.
Countries holding a registration under ATC M05BX07 (vosoritide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Vosoritide · ATC M05BX07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Vosoritidum
- Manufacturer
- BioMarin International Ltd.
- Country
- Poland (PL)
- ATC code
- M05BX07
- ATC class
- Vosoritide
- Defined daily dose
- 0.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05391524462890
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vosoritide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVoxzogo 0.4 mgBioMarin International
- SwitzerlandVoxzogo 0.4 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungDRAC AG
- SpainVOXZOGO 0,4 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBiomarin International Limited
- IcelandVoxzogoBioMarin International Limited
- SwedenVoxzogo 0,4 mg Pulver och vätska till injektionsvätska, lösningBioMarin International Limited
- NetherlandsVoxzogo 0,4 mg, poeder en oplosmiddel voor oplossing voor injectieBioMarin International Limited
- CzechiaVOXZOGOBioMarin International Limited, Dublin
- FinlandVoxzogoBiomarin International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voxzogo
- Liechtenstein · Voxzogo
- Norway · Voxzogo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75c36957-705e-4181-9e91-574496b4e489 GET /v1/drugs/75c36957-705e-4181-9e91-574496b4e489?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "0,4 mg",
"packaging": "Rpz ¦ EU/1/21/1577/001 ¦ 141882\n10 fiol. proszku ¦ 10 amp.-strzyk. 0,5 ml rozp. ¦ 10 igieł ¦ 10 strzyk. \n¦ UR/Z/4b/018/24 - 05391524462890 ¦ UR/Z/4b/066/23 - 05391524462890 ¦ UR/Z/4b/167/24 - 05391524462890 ¦ UR/Z/4b/035/22 - 05391524462890 ¦ UR/Z/4b/182/25 - 05391524462890 ¦ UR/Z/4b/106/25 - 05391524462890 ¦ UR/Z/4b/271/25 - 05391524462890 ¦ UR/Z/4b/069/26 - 05391524462890 ¦ UR/Z/4b/133/26 - 05391524462890 ¦ UR/Z/4b/175/26 - 05391524462890",
"substance": "Vosoritidum 0.4 mg",
"common_name": "Vosoritidum",
"pl_product_id": "100457685",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about vosoritide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.